Corporate information

Official name
Raven Biotechnologies Incorporated
Registration country

Company type

A biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer.

Funding rounds

Acquisition


( )

Profile Country
MacroGenics Inc Biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases.

Series D


( )

Profile Country
Vulcan Inc (Vulcan Capital)

Series D


( )

Profile Country
Biogen Idec New Ventures

Series D


( )

Profile Country Notes
The Bank of Tokyo - Mitsubishi UFJ Capital Co Ltd Initial investment.

Series D


( )

Profile Country
Pequot Ventures

Series D


( )

Profile Country
US Venture Partners. (USVP) Silicon Valley venture capital firm.

Series D


( )


Series D


( )

Profile Country
Milepost Ventures

Profile Country
Integra Ventures

Profile Country
Western Technology Investment (WTI) Venture debt firm investing debt and equity capital in venture-backed technology, healthcare and clean technology companies.

Profile Country
Bio*One Capital Pte Ltd

Profile Country
CMEA Capital (CMEA Ventures), (Chemical and Materials Enterprise Associates)

Profile Country
EDB Investments Pte (EDBi) The venture arm of Singapore's Economic Development Board.

Profile Country
FirstMark Capital LLC Venture capital firm

Profile Country
Mitsubishi Corp


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials